CFD 属于复杂的高风险金融工具,其杠杆作用可能导致投资者迅速亏损。 84% 的散户投资者因进行 CFD 交易遭受资金损失。 请您谨慎考虑自己是否了解 CFD 操作,以及是否能够接受高额亏损的风险。

Scan to Download iOS&Android APP

交易 Calcimedica Inc - CALC CFD

5.5768
7.77%
  • 概括
  • 历史数据
  • 活动
  • 收入报表
  • 资产负债表
  • 现金流
  • 所有权
交易条件
价差 0.6864
多头隔夜费

Long position overnight fee


Margin. Your investment $1,000.00
隔夜费用 -0.024068 %
Charges from borrowed part ($-0.96)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

前往平台
-0.024068%
空头隔夜费

Short position overnight fee


Margin. Your investment $1,000.00
隔夜费用 0.001846 %
Charges from borrowed part ($0.07)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

前往平台
0.001846%
隔夜费时间 21:00 (UTC)
最小交易量 0.001
货币 USD
保证金 20%
上市交易所 United States of America
交易费 0%

*Information provided by Capital.com

关键数据
前收盘价* 6.0468
开盘价* 5.4889
1 年变化* 319%
日范围* 5.341 - 6.2951
52 周范围 4.88-20.44
平均交易量(10 天) 13.44K
平均交易量(3 个月) 74.39K
市值 9.95M
市盈率 -100.00K
流通股 1.57M
收入 N/A
EPS -23.21
股息(收益率 %) N/A
贝塔 -100.00K
下一个财报发布日期 May 8, 2023

所有数据都是由Refinitiv提供的, 除了标有星号的数据, 这是*由 Capital.com 提供的数据

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date 平倉 Change Change (%) 開倉 High Low
Mar 22, 2023 5.5768 0.2301 4.30% 5.3467 6.5507 5.0805
Mar 21, 2023 6.0468 1.2311 25.56% 4.8157 6.1436 4.7284
Mar 20, 2023 5.3451 -0.6469 -10.80% 5.9920 5.9920 5.0602
Mar 17, 2023 0.4280 -0.0478 -10.05% 0.4758 0.4763 0.4273
Mar 16, 2023 0.4761 -0.0195 -3.93% 0.4956 0.4958 0.4580
Mar 15, 2023 0.4937 0.0277 5.94% 0.4660 0.4969 0.4660
Mar 14, 2023 0.4762 -0.0145 -2.95% 0.4907 0.4957 0.4737
Mar 13, 2023 0.4960 -0.0093 -1.84% 0.5053 0.5151 0.4859
Mar 10, 2023 0.5041 0.0008 0.16% 0.5033 0.5120 0.4857
Mar 9, 2023 0.5346 -0.0034 -0.63% 0.5380 0.5637 0.5164
Mar 8, 2023 0.5638 0.0408 7.80% 0.5230 0.5647 0.5230
Mar 7, 2023 0.5637 0.0395 7.54% 0.5242 0.5823 0.5242
Mar 6, 2023 0.5556 -0.0273 -4.68% 0.5829 0.5829 0.5537
Mar 3, 2023 0.5476 0.0429 8.50% 0.5047 0.5588 0.5047
Mar 2, 2023 0.5345 0.0292 5.78% 0.5053 0.5347 0.5053
Mar 1, 2023 0.5390 0.0045 0.84% 0.5345 0.5832 0.5339
Feb 28, 2023 0.5285 -0.0056 -1.05% 0.5341 0.5347 0.5179
Feb 27, 2023 0.5536 -0.0004 -0.07% 0.5540 0.5543 0.5343
Feb 24, 2023 0.5439 -0.0390 -6.69% 0.5829 0.5975 0.5273
Feb 23, 2023 0.5915 0.0065 1.11% 0.5850 0.6124 0.5837

Calcimedica Inc Events

時間(協調世界時) (UTC) 國家 事件
No events scheduled
查看所有活動
  • 年度
  • 每季度
2021 2020 2019 2018
总收入 0 0 0 0
总营业费用 35.947 29.832 37.502 28.57
销售/一般/行政费用,总计 17.044 8.87 6.922 5.599
研究与开发 18.903 20.962 30.58 22.971
营业收入 -35.947 -29.832 -37.502 -28.57
利息收入(费用),非经营净值 0.126 0.143 0.393 0.192
其他,净值 0 2.158 0.072 0
税前净收入 -35.821 -27.531 -37.037 -28.378
税后净收入 -35.821 -27.531 -37.037 -28.378
未计算非常项目前的净收益 -35.821 -27.531 -37.037 -28.378
净收入 -35.821 -27.531 -37.037 -28.378
Total Adjustments to Net Income 0 -7.189 -7.055 -4.317
普通股股东可获收益 (不含非经常性项目) -35.821 -34.72 -44.092 -32.695
普通股股东可获收益 (含非經常性項目) -35.821 -34.72 -44.092 -32.695
摊薄净收入 -35.821 -34.72 -44.092 -32.695
摊薄后加权平均股 21.1993 21.044 19.1556 19.1556
扣除特别项目的每股摊薄盈利 -1.68973 -1.64988 -2.30178 -1.70681
Dividends per Share - Common Stock Primary Issue 0 0
每股正常摊薄盈利 -1.68973 -1.64988 -2.30178 -1.70681
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
总收入 0 0 0 0 0
总营业费用 10.184 8.701 8.017 7.741 11.488
销售/一般/行政费用,总计 4.127 4.433 3.996 3.575 5.04
研究与开发 6.057 4.268 4.021 4.166 6.448
营业收入 -10.184 -8.701 -8.017 -7.741 -11.488
利息收入(费用),非经营净值 0.035 0.026 0.028 0.033 0.039
其他,净值 0 0 0 0
税前净收入 -10.149 -8.675 -7.989 -7.708 -11.449
税后净收入 -10.149 -8.675 -7.989 -7.708 -11.449
未计算非常项目前的净收益 -10.149 -8.675 -7.989 -7.708 -11.449
净收入 -10.149 -8.675 -7.989 -7.708 -11.449
Total Adjustments to Net Income 0 0 0 0
普通股股东可获收益 (不含非经常性项目) -10.149 -8.675 -7.989 -7.708 -11.449
普通股股东可获收益 (含非經常性項目) -10.149 -8.675 -7.989 -7.708 -11.449
摊薄净收入 -10.149 -8.675 -7.989 -7.708 -11.449
摊薄后加权平均股 21.3578 21.3376 21.2875 21.1487 21.0204
扣除特别项目的每股摊薄盈利 -0.47519 -0.40656 -0.37529 -0.36447 -0.54466
Dividends per Share - Common Stock Primary Issue 0 0 0 0
每股正常摊薄盈利 -0.47519 -0.40656 -0.37529 -0.36447 -0.54466
  • 年度
  • 每季度
2021 2020 2019 2018
流动资产总额 67.078 99.24 36.271 13.445
现金和短期投资 63.67 95.033 35.956 12.834
现金等价物 13.364 33.418 15.87 12.834
短期投资 50.306 61.615 20.086 0
Prepaid Expenses 2.034 4.207 0.315 0.611
Total Assets 69.088 101.794 40.66 17.813
Property/Plant/Equipment, Total - Net 1.981 1.946 1.975 1.515
Property/Plant/Equipment, Total - Gross 3.634 3.08 2.714 1.958
Accumulated Depreciation, Total -1.653 -1.134 -0.739 -0.443
Other Long Term Assets, Total 0.029 0.608 2.414 2.853
Total Current Liabilities 4.057 6.997 12.251 5.794
Accounts Payable 0.527 2.513 4.636 2.523
Accrued Expenses 2.582 3.658 4.377 2.924
Notes Payable/Short Term Debt 0 0 0 0
Other Current Liabilities, Total 0.948 0.826 3.238 0.347
Total Liabilities 4.065 7.008 12.251 5.794
Total Long Term Debt 0 0 0 0
Total Equity 65.023 94.786 28.409 12.019
Preferred Stock - Non Redeemable, Net 0 0 131.363 78.811
Common Stock 0.002 0.002 0 0
Additional Paid-In Capital 234.225 228.155 2.879 2.007
Retained Earnings (Accumulated Deficit) -169.188 -133.367 -105.836 -68.799
Unrealized Gain (Loss) -0.016 -0.004 0.003 0
Total Liabilities & Shareholders’ Equity 69.088 101.794 40.66 17.813
Total Common Shares Outstanding 21.3578 20.9793 19.1556 19.1556
Other Liabilities, Total 0.008 0.011
Total Preferred Shares Outstanding 0
应收账款总额,净额 0.021
Other Current Assets, Total 1.353
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
流动资产总额 58.222 67.078 74.496 76.051 88.821
现金和短期投资 55.28 63.67 72.554 73.586 85.688
现金等价物 8.36 13.364 11.452 7.864 10.589
短期投资 46.92 50.306 61.102 65.722 75.099
Prepaid Expenses 2.942 3.408 1.942 2.465 3.133
Total Assets 60.586 69.088 76.638 82.821 90.852
Property/Plant/Equipment, Total - Net 2.335 1.981 2.113 2.006 2.002
Other Long Term Assets, Total 0.029 0.029 0.029 0.136 0.029
Total Current Liabilities 4.228 4.057 4.49 4.141 6.278
Accounts Payable 0.541 0.527 2.066 2.101 1.956
Accrued Expenses 2.216 2.582 1.729 1.543 3.378
Notes Payable/Short Term Debt 0 0 0 0 0
Other Current Liabilities, Total 1.471 0.948 0.695 0.497 0.944
Total Liabilities 4.33 4.065 4.502 4.154 6.29
Total Long Term Debt 0 0 0 0 0
Other Liabilities, Total 0.102 0.008 0.012 0.013 0.012
Total Equity 56.256 65.023 72.136 78.667 84.562
Common Stock 0.002 0.002 0.002 0.002 0.002
Additional Paid-In Capital 235.767 234.225 232.641 231.183 229.376
Retained Earnings (Accumulated Deficit) -179.337 -169.188 -160.513 -152.524 -144.816
Unrealized Gain (Loss) -0.176 -0.016 0.006 0.006 0
Total Liabilities & Shareholders’ Equity 60.586 69.088 76.638 82.821 90.852
Total Common Shares Outstanding 21.3578 21.3578 21.3166 21.2847 21.0559
Long Term Investments 4.628
Preferred Stock - Non Redeemable, Net 0 0
  • 年度
  • 每季度
2021 2020 2019 2018
净收入/起跑线 -35.821 -27.531 -37.037 -28.378
经营活动产生的现金 -31.5 -32.064 -31.215 -28.216
经营活动产生的现金 0.519 0.395 0.303 0.175
非现金物品 5.433 -0.369 0.598 0.366
营运资金的变化 -1.631 -4.559 4.921 -0.379
投资活动产生的现金 10.751 -42.56 -20.62 -1.461
资本支出 -0.488 -1.023 -0.605 -1.461
其他投资现金流量项目,总计 11.239 -41.537 -20.015 0
融资活动产生的现金 0.695 92.172 54.871 42.019
融资现金流项目 0 -4.16 -0.045 0
股票的发行(报废),净额 0.695 96.332 54.916 42.019
现金净变化 -20.054 17.548 3.036 12.342
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Net income/Starting Line -10.149 -35.821 -27.146 -19.157 -11.449
Cash From Operating Activities -6.524 -31.5 -22.545 -17.045 -9.264
Cash From Operating Activities 0.122 0.519 0.383 0.247 0.118
Non-Cash Items 3.81 5.433 3.946 2.508 1.169
Changes in Working Capital -0.307 -1.631 0.272 -0.643 0.898
Cash From Investing Activities 1.52 10.751 -0.035 -9.096 -13.657
Capital Expenditures 0 -0.488 -0.484 -0.304 -0.136
Other Investing Cash Flow Items, Total 1.52 11.239 0.449 -8.792 -13.521
Cash From Financing Activities 0 0.695 0.614 0.587 0.092
Financing Cash Flow Items 0 0 0 0
Issuance (Retirement) of Stock, Net 0 0.695 0.614 0.587 0.092
Net Change in Cash -5.004 -20.054 -21.966 -25.554 -22.829

为什么选择 Capital.com?让我们的数字来说话。

Capital.com Group

500K+

交易者

92K+

每月活跃客户

$53M+

每月投资额

$30M+

每月提取金额

交易計算器

如果您在特定日期(选择一个日期)开立差价合约交易并在不同日期(选择一个日期)关闭交易,计算您的假设盈亏。

貿易佣金
0
  • 1:1
杠杆
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
投資
交易規模(槓桿 x 投資):
開倉

平倉

做空 做多

Graybug Vision, Inc. Company profile

关于 Graybug Vision Inc.

Graybug Vision, Inc.是一家临床阶段的生物制药公司,致力于开发治疗视网膜和视神经疾病的变革性药物。 公司的主要候选产品GB-102是一种玻璃体内注射舒尼替尼的微粒子制剂,舒尼替尼是一种新生血管生长和渗透性的抑制剂,而新生血管生长和渗透性是导致视网膜疾病的原因。 该公司正在开发GB-102,作为每六个月一次的玻璃体内注射,用于治疗湿性年龄相关性黄斑变性或湿性(AMD)和糖尿病黄斑水肿(DME)。 该公司还在利用其技术开发GB-103,一种一年一次的GB-102制剂,用于治疗糖尿病视网膜病变(DR),以及GB-401,一种玻璃体内注射的β-肾上腺素能阻断剂原药制剂,用药方案为每六个月一次或更长,用于治疗原发性开角型青光眼(POAG)。

Industry: Bio Therapeutic Drugs

274 Redwood Shores Parkway
P.O. Box 144
REDWOOD CITY
CALIFORNIA 94065
US

收入报表

  • Annual
  • Quarterly

人们也观看

US100

12,693.10 Price
+1.040% 1D Chg, %
多头隔夜费 -0.0241%
空头隔夜费 0.0018%
隔夜费时间 21:00 (UTC)
价差 1.8

BTC/USD

27,654.45 Price
+0.750% 1D Chg, %
多头隔夜费 -0.0616%
空头隔夜费 0.0137%
隔夜费时间 21:00 (UTC)
价差 60.00

Oil - Crude

70.43 Price
+0.760% 1D Chg, %
多头隔夜费 -0.0170%
空头隔夜费 -0.0050%
隔夜费时间 21:00 (UTC)
价差 0.03

XRP/USD

0.44 Price
+3.420% 1D Chg, %
多头隔夜费 -0.0753%
空头隔夜费 0.0069%
隔夜费时间 21:00 (UTC)
价差 0.00459

还在找一位您可以信任的经纪商吗?

加入成为全球500,000万多名交易者的一份子,选择利用Capital.com进行交易吧。

1. 创建和验证您的账户 2. 进行存款 3. 找到适合您的交易